Derek A. Bertocci, Chief Financial Officer at Guardant Health, Inc. (GH), sold 50,000 shares at $85.30 ($4.4M) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Open-market sale of $4.4M GH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.30 | 1,113 | $95K | 2.2% |
| 2 | $85.30 | 1,113 | $95K | 2.2% |
| 3 | $86.72 | 6,136 | $532K | 12.1% |
| 4 | $86.72 | 6,136 | $532K | 12.1% |
| 5 | $87.38 | 6,218 | $543K | 12.4% |
| 6 | $87.38 | 6,218 |
| $543K |
| 12.4% |
| 7 | $88.55 | 8,673 | $768K | 17.5% |
| 8 | $88.55 | 8,673 | $768K | 17.5% |
| 9 | $89.38 | 2,860 | $256K | 5.8% |
| 10 | $89.38 | 2,860 | $256K | 5.8% |
| Total | $87.76 avg | 50,000 | $4.4M | 100% |
| Filing → |
| GH | SELL | 2020-05-26 | $1.7M | — | Filing → |
| GH | SELL | 2020-05-12 | $4.2M | — | Filing → |
| GH | SELL | 2020-03-25 | $2.3M | — | Filing → |